MAPK3 and Parkinson disease: Mechanistically, it was found that the protective effects of FTY in Parkinson’s disease were correlated with the activation of survival pathway mediated by Akt/ERK1/2 and increased expression of a neuron-specific brain-derived neurotrophic factor (BDNF).